Cell biology: Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors

Science Signaling

Volumn 5, Issue 216, 2012, Pages

  Varfolomeev, Eugene ^a   Goncharov, Tatiana ^a   Maecker, Heather ^a   Zobel, Kerry ^a   Kömüves, László G ^a   Deshayes, Kurt ^a   Vucic, Domagoj ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; I KAPPA B; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; I KAPPA B KINASE INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEASOME; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UBIQUITIN PROTEIN LIGASE E3; CARRIER PROTEIN; I KAPPA B KINASE; IKBKG PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RNF31 PROTEIN, HUMAN; SMALL INTERFERING RNA; UBIQUITIN;

APOPTOSIS; ARTICLE; CANONICAL ANALYSIS; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; HUMAN; HUMAN CELL; LYSOSOME; PRIORITY JOURNAL; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

INTRACISTERNAL A-PARTICLES;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; GENE SILENCING; HUMANS; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN TRANSPORT; RECEPTORS, INTERLEUKIN-4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTORS; UBIQUITIN;

EID: 84858627919     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001878     Document Type: Article

References (60)

1. J. L. Bodmer, P. Schneider, J. Tschopp, The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26 (2002).
2. R. M. Locksley, N. Killeen, M. J. Lenardo, The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104, 487-501 (2001).
3. D. Wallach, T. U. Arumugam, M. P. Boldin, G. Cantarella, K. A. Ganesh, Y. Goltsev, T. M. Goncharov, A. V. Kovalenko, A. Rajput, E. E. Varfolomeev, S. Q. Zhang, How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family. Arthritis Res. 4 (suppl. 3), S189-S196 (2002).
4. H. Häcker, M. Karin, Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
5. H. Li, X. Lin, Positive and negative signaling components involved in TNFα-induced NF-κB activation. Cytokine 41, 1-8 (2008).
6. E. F. Wagner, A. R. Nebreda, Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549 (2009).
7. V. Baud, M. Karin, Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377 (2001).
8. C. Scheidereit, IκB kinase complexes: Gateways to NF-κB activation and transcription. Oncogene 25, 6685-6705 (2006).
9. E. Dejardin, The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179 (2006).
10. E. Varfolomeev, D. Vucic, (Un)expected roles of c-IAPs in apoptotic and NFκB signaling pathways. Cell Cycle 7, 1511-1521 (2008).
11. J. Silke, R. Brink, Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ. 17, 35-45 (2010).
12. I. E. Wertz, V. M. Dixit, Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev. 19, 313-324 (2008).
13. M. J. Bertrand, S. Milutinovic, K. M. Dickson, W. C. Ho, A. Boudreault, J. Durkin, J. W. Gillard, J. B. Jaquith, S. J. Morris, P. A. Barker, cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700 (2008).
14. T. L. Haas, C. H. Emmerich, B. Gerlach, A. C. Schmukle, S. M. Cordier, E. Rieser, R. Feltham, J. Vince, U. Warnken, T. Wenger, R. Koschny, D. Komander, J. Silke, H. Walczak, Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844 (2009).
15. O. Micheau, J. Tschopp, Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190 (2003).
16. E. Varfolomeev, T. Goncharov, A. V. Fedorova, J. N. Dynek, K. Zobel, K. Deshayes, W. J. Fairbrother, D. Vucic, c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295-24299 (2008).
17. J. N. Dynek, T. Goncharov, E. C. Dueber, A. V. Fedorova, A. Izrael-Tomasevic, L. Phu, E. Helgason, W. J. Fairbrother, K. Deshayes, D. S. Kirkpatrick, D. Vucic, c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198-4209 (2010).
18. S. L. Rowland, M. M. Tremblay, J. M. Ellison, L. L. Stunz, G. A. Bishop, B. S. Hostager, A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. J. Immunol. 179, 4645-4653 (2007).
19. E. Dejardin, N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, D. R. Green, The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17, 525-535 (2002).
20. S. A. Brown, C. M. Richards, H. N. Hanscom, S. L. Feng, J. A. Winkles, The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation. Biochem. J. 371, 395-403 (2003).
21. Y. H. Chang, S. L. Hsieh, M. C. Chen, W. W. Lin, Lymphotoxin b receptor induces interleukin 8 gene expression via NF-κB and AP-1 activation. Exp. Cell Res. 278, 166-174 (2002).
22. Y. S. Kim, S. A. Nedospasov, Z. G. Liu, TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin β receptor signaling. Mol. Cell. Biol. 25, 2130-2137 (2005).
23. F. Meylan, T. S. Davidson, E. Kahle, M. Kinder, K. Acharya, D. Jankovic, V. Bundoc, M. Hodges, E. M. Shevach, A. Keane-Myers, E. C. Wang, R. M. Siegel, The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89 (2008).
24. L. Wen, L. Zhuang, X. Luo, P. Wei, TL1A-induced NF-κB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J. Biol. Chem. 278, 39251-39258 (2003).
25. M. Rothe, M. G. Pan, W. J. Henzel, T. M. Ayres, D. V. Goeddel, The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252 (1995).
26. E. Varfolomeev, J.W. Blankenship, S. M.Wayson, A. V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J. N. Dynek, L. O. Elliott, H. J. Wallweber, J. A. Flygare, W. J. Fairbrother, K. Deshayes, V. M. Dixit, D. Vucic, IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669-681 (2007).
27. D. L. Vaux, J. Silke, IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6, 287-297 (2005).
28. X. Li, Y. Yang, J. D. Ashwell, TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345-347 (2002).
29. J. E. Vince, D. Pantaki, R. Feltham, P. D. Mace, S. M. Cordier, A. C. Schmukle, A. J. Davidson, B. A. Callus, W. W. Wong, I. E. Gentle, H. Carter, E. F. Lee, H. Walczak, C. L. Day, D. L. Vaux, J. Silke, TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-κB and to prevent TNF-induced apoptosis. J. Biol. Chem. 284, 35906-35915 (2009).
30. A. Matsuzawa, P. H. Tseng, S. Vallabhapurapu, J. L. Luo, W. Zhang, H. Wang, D. A. Vignali, E. Gallagher, M. Karin, Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663-668 (2008).
31. S. Vallabhapurapu, A. Matsuzawa, W. Zhang, P. H. Tseng, J. J. Keats, H. Wang, D. A. Vignali, P. L. Bergsagel, M. Karin, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364-1370 (2008).
32. J. E. Vince, D. Chau, B. Callus, W. W. Wong, C. J. Hawkins, P. Schneider, M. McKinlay, C. A. Benetatos, S. M. Condon, S. K. Chunduru, G. Yeoh, R. Brink, D. L. Vaux, J. Silke, TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα. J. Cell Biol. 182, 171-184 (2008).
33. B. J. Zarnegar, Y.Wang, D. J. Mahoney, P. W. Dempsey, H. H. Cheung, J. He, T. Shiba, X. Yang, W. C. Yeh, T. W. Mak, R. G. Korneluk, G. Cheng, Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378 (2008).
34. D. J. Mahoney, H. H. Cheung, R. L. Mrad, S. Plenchette, C. Simard, E. Enwere, V. Arora, T. W. Mak, E. C. Lacasse, J. Waring, R. G. Korneluk, Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 105, 11778-11783 (2008).
35. M. Muzio, B. R. Stockwell, H. R. Stennicke, G. S. Salvesen, V. M. Dixit, An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930 (1998).
36. L. Bouchier-Hayes, A. Oberst, G. P. McStay, S. Connell, S. W. Tait, C. P. Dillon, J. M. Flanagan, H. M. Beere, D. R. Green, Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol. Cell 35, 830-840 (2009).
37. E. Claudio, K. Brown, S. Park, H. Wang, U. Siebenlist, BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3, 958-965 (2002).
38. N. Kayagaki, M. Yan, D. Seshasayee, H. Wang, W. Lee, D. M. French, I. S. Grewal, A. G. Cochran, N. C. Gordon, J. Yin, M. A. Starovasnik, V. M. Dixit, BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity 17, 515-524 (2002).
39. L. G. Xu, H. B. Shu, TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-κB activation and IL-10 production. J. Immunol. 169, 6883-6889 (2002).
40. C. Z. Ni, G. Oganesyan, K. Welsh, X. Zhu, J. C. Reed, A. C. Satterthwait, G. Cheng, K. R. Ely, Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: Implications for intracellular signaling regulation. J. Immunol. 173, 7394-7400 (2004).
41. J. J. Keats, R. Fonseca, M. Chesi, R. Schop, A. Baker, W. J. Chng, S. Van Wier, R. Tiedemann, C. X. Shi, M. Sebag, E. Braggio, T. Henry, Y. X. Zhu, H. Fogle, T. Price-Troska, G. Ahmann, C. Mancini, L. A. Brents, S. Kumar, P. Greipp, A. Dispenzieri, B. Bryant, G. Mulligan, L. Bruhn, M. Barrett, R. Valdez, J. Trent, A. K. Stewart, J. Carpten, P. L. Bergsagel, Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 12, 131-144 (2007).
42. J. Moreaux, E. Legouffe, E. Jourdan, P. Quittet, T. Reme, C. Lugagne, P. Moine, J. F. Rossi, B. Klein, K. Tarte, BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103, 3148-3157 (2004).
43. G. A. Bishop, C. R. Moore, P. Xie, L. L. Stunz, Z. J. Kraus, TRAF proteins in CD40 signaling. Adv. Exp. Med. Biol. 597, 131-151 (2007).
44. Q. Yin, B. Lamothe, B. G. Darnay, H. Wu, Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48, 10558-10567 (2009).
45. Q. Yin, S. C. Lin, B. Lamothe, M.Lu, Y. C. Lo, G. Hura, L. Zheng, R. L. Rich, A.D. Campos, D. G. Myszka, M. J. Lenardo, B. G. Darnay, H. Wu, E2 interaction and dimerization in the crystal structure of TRAF6. Nat. Struct. Mol. Biol. 16, 658-666 (2009).
46. J. E. Vince, W. W. Wong, N. Khan, R. Feltham, D. Chau, A. U. Ahmed, C. A. Benetatos, S. K. Chunduru, S. M. Condon, M. McKinlay, R. Brink, M. Leverkus, V. Tergaonkar, P. Schneider, B. A. Callus, F. Koentgen, D. L. Vaux, J. Silke, IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131, 682-693 (2007).
47. A. Kovalenko, D. Wallach, If the prophet does not come to the mountain: Dynamics of signaling complexes in NF-κB activation. Mol. Cell 22, 433-436 (2006).
48. F. Tokunaga, S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako, K. Kamei, T. Nakagawa, M. Kato, S. Murata, S. Yamaoka, M. Yamamoto, S. Akira, T. Takao, K. Tanaka, K. Iwai, Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123-132 (2009).
49. J. R. Arron, Y. Pewzner-Jung, M. C. Walsh, T. Kobayashi, Y. Choi, Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 196, 923-934 (2002).
50. K. D. Brown, B. S. Hostager, G. A. Bishop, Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277, 19433-19438 (2002).
51. C. J. Wu, D. B. Conze, X. Li, S. X. Ying, J. A. Hanover, J. D. Ashwell, TNF-α induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 24, 1886-1898 (2005).
52. Z. P. Xia, Z. J. Chen, TRAF2: A double-edged sword? Sci. STKE 2005, pe7 (2005).
53. P. D. Mace, C. Smits, D. L. Vaux, J. Silke, C. L. Day, Asymmetric recruitment of cIAPs by TRAF2. J. Mol. Biol. 400, 8-15 (2010).
54. C. Zheng, V. Kabaleeswaran, Y. Wang, G. Cheng, H. Wu, Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: Affinity, specificity, and regulation. Mol. Cell 38, 101-113 (2010).
55. P. D. Mace, K. Linke, R. Feltham, F. R. Schumacher, C. A. Smith, D. L. Vaux, J. Silke, C. L. Day, Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J. Biol. Chem. 283, 31633-31640 (2008).
56. C. Ndubaku, F. Cohen, E. Varfolomeev, D. Vucic, Targeting inhibitor of apoptosis proteins for therapeutic intervention. Future Med. Chem. 1, 1509-1525 (2009).
57. A. Johnston, S. L. Sigurdardottir, J. J. Ryon, Isolation of mononuclear cells from tonsillar tissue. Curr. Protoc. Immunol. Chapter 7, Unit 7.8 (2009).
58. J. N. Dynek, T. Goncharov, E. C. Dueber, A. V. Fedorova, A. Izrael-Tomasevic, L. Phu, E. Helgason, W. J. Fairbrother, K. Deshayes, D. S. Kirkpatrick, D. Vucic, c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198-4209 (2010).
59. C. V. Lee, S. G. Hymowitz, H. J. Wallweber, N. C. Gordon, K. L. Billeci, S. P. Tsai, D. M. Compaan, J. Yin, Q. Gong, R. F. Kelley, L. E. DeForge, F. Martin, M. A. Starovasnik, G. Fuh, Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 108, 3103-3111 (2006).
60. D. Seshasayee, P. Valdez, M. Yan, V. M. Dixit, D. Tumas, I. S. Grewal, Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18, 279-288 (2003).